Fig 1 shows the histogram of serum adiponectin levels of patients divided into each treatment group. Although previous studies have shown that serum adiponectin levels are affected by RA therapeutics such as anti-TNFα treatments [22, 25], our data indicate that biological agents and JAK inhibitor do not significantly affect serum adiponectin levels. This evidence concerns the gene ADIPOQ and rheumatoid arthritis.